IN2013DE03033A - - Google Patents

Info

Publication number
IN2013DE03033A
IN2013DE03033A IN3033DE2013A IN2013DE03033A IN 2013DE03033 A IN2013DE03033 A IN 2013DE03033A IN 3033DE2013 A IN3033DE2013 A IN 3033DE2013A IN 2013DE03033 A IN2013DE03033 A IN 2013DE03033A
Authority
IN
India
Prior art keywords
drug
type transdermal
dia
active
transdermal patch
Prior art date
Application number
Inventor
Chattopadhyay Pronobesh
Banerjee Subham
Ghosh Animesh
Veer Vijay
Original Assignee
Director General Defence Res & Dev Org
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Director General Defence Res & Dev Org filed Critical Director General Defence Res & Dev Org
Priority to IN3033DE2013 priority Critical patent/IN2013DE03033A/en
Publication of IN2013DE03033A publication Critical patent/IN2013DE03033A/en

Links

Abstract

A drug in adhesive (DIA) type transdermal patch for sustaining controlled drug/active release for the treatment of acetylcholine agonist (±) anatoxin-A poisoning involving a select combination of drug/active composed of eserine and pralidoxime chloride (2-PAM) which would facilitate controlled sustained release of the drug/active The DIA matrix type transdermal patch can be generally thin, circular, smooth, uniform and flexible in nature, and can be applied to 'dermal surface' including (i) intact , unbroken skin (ii) skin which is open e.g. lacerated,burned,blistered and the like and (iii) mucosal tissue. Advantageously, the DIA matrix type transdermal patch against acetylcholine agonist neutotoxin poisoning is found to be effective as non-invasive type transdermal drug sustained release delivery systems for a period of upto about 72 hours. Fig. 1
IN3033DE2013 2013-10-10 2013-10-10 IN2013DE03033A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3033DE2013 IN2013DE03033A (en) 2013-10-10 2013-10-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3033DE2013 IN2013DE03033A (en) 2013-10-10 2013-10-10

Publications (1)

Publication Number Publication Date
IN2013DE03033A true IN2013DE03033A (en) 2015-04-17

Family

ID=54397084

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3033DE2013 IN2013DE03033A (en) 2013-10-10 2013-10-10

Country Status (1)

Country Link
IN (1) IN2013DE03033A (en)

Similar Documents

Publication Publication Date Title
MX2013005581A (en) Transdermal therapeutic system for administering an active substance.
MX366560B (en) Adhesive patch with antimicrobial composition.
MX2017012321A (en) Microneedle patch for delivering an active ingredient to skin.
HK1143301A1 (en) Apparatus for the formation of multiple microconduits
WO2011076621A3 (en) Transdermal therapeutic system for administering rivastigmine or derivatives thereof
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
WO2011069141A3 (en) Interferon therapies in combination with blockade of stat3 activation
WO2010111178A3 (en) Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
GB2465677B (en) Non-systemic delivery of satiogens for use in the treatment of obesity and/or diabetes
MY160388A (en) A scaffold material for wound care and/or other tissue healing applications
WO2013036513A3 (en) Medical bandages with a skin adhesion reducing material
PH12015501169A1 (en) Transdermal delivery system
MX2012014521A (en) Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation.
IN2012DN01225A (en)
NZ603913A (en) Method of engrafting cells from solid tissues
MX2015008286A (en) Multi-polymer compositions for transdermal drug delivery.
MX365688B (en) Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin.
WO2011088072A3 (en) Dermal delivery device
WO2008151040A3 (en) Analgesic coated medical product
MX367070B (en) Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine.
WO2014153385A3 (en) Methods of treating metabolic disorders
AU2014203502B2 (en) Once-a-day replacement transdermal administration of fentanyl
IN2013DE03033A (en)
MX2015010967A (en) Transdermal formulations of laquinimod.
WO2011028797A3 (en) Treatment of glaucoma and other retinopathies with gangliosides